Table 1 Basic characteristics in all patients.
Total | Train | Test | External | P-value | |
|---|---|---|---|---|---|
Progression of disease | |||||
TIE | 239 (73.1%) | 110 (72.4%) | 53 (77.9%) | 76 (71.0%) | 0.59 |
TIN | 88 (26.9%) | 42 (27.6%) | 15 (22.1%) | 31 (29.0%) | |
OS | |||||
Live | 239 (73.1%) | 110 (72.4%) | 53 (77.9%) | 76 (71.0%) | 0.59 |
Die | 88 (26.9%) | 42 (27.6%) | 15 (22.1%) | 31 (29.0%) | |
NLR | |||||
<=3 | 177 (54.1%) | 84 (55.3%) | 37 (54.4%) | 56 (52.3%) | 0.92 |
>3 | 150 (45.9%) | 68 (44.7%) | 31 (45.6%) | 51 (47.7%) | |
ΔT | |||||
<0 | 145 (44.3%) | 68 (44.7%) | 26 (38.2%) | 51 (47.7%) | 0.48 |
>=0 | 182 (55.7%) | 84 (55.3%) | 42 (61.8%) | 56 (52.3%) | |
ΔP | |||||
<0 | 263 (80.4%) | 121 (79.6%) | 56 (82.4%) | 86 (80.4%) | 0.92 |
>=0 | 64 (19.6%) | 31 (20.4%) | 12 (17.6%) | 21 (19.6%) | |
Statelite nodule | |||||
Yes | 301 (92.0%) | 139 (91.4%) | 63 (92.6%) | 99 (92.5%) | 0.96 |
No | 26 (8.0%) | 13 (8.6%) | 5 (7.4%) | 8 (7.5%) | |
Sex | |||||
Male | 287 (87.8%) | 133 (87.5%) | 60 (88.2%) | 94 (87.9%) | 1 |
Female | 40 (12.2%) | 19 (12.5%) | 8 (11.8%) | 13 (12.1%) | |
Echo of tumor | |||||
Homogeneous | 211 (64.5%) | 92 (60.5%) | 46 (67.6%) | 73 (68.2%) | 0.39 |
Heterogeneous | 116 (35.5%) | 60 (39.5%) | 22 (32.4%) | 34 (31.8%) | |
Capsual of tumor | |||||
Clear | 40 (12.2%) | 21 (13.8%) | 5 (7.4%) | 14 (13.1%) | 0.4 |
Obscure | 287 (87.8%) | 131 (86.2%) | 63 (92.6%) | 93 (86.9%) | |
Collateral circulation | |||||
No | 244 (74.6%) | 110 (72.4%) | 57 (83.8%) | 77 (72.0%) | 0.14 |
Yes | 83 (25.4%) | 42 (27.6%) | 11 (16.2%) | 30 (28.0%) | |
AFP | |||||
<200 | 120 (36.7%) | 58 (38.2%) | 26 (38.2%) | 36 (33.6%) | 0.74 |
>200 | 207 (63.3%) | 94 (61.8%) | 42 (61.8%) | 71 (66.4%) | |
Macrovascular invansion | |||||
No | 121 (37.0%) | 61 (40.1%) | 25 (36.8%) | 35 (32.7%) | 0.47 |
Yes | 206 (63.0%) | 91 (59.9%) | 43 (63.2%) | 72 (67.3%) | |
Viral hepatitis | |||||
Non-HBV | 37 (11.3%) | 19 (12.5%) | 3 (4.4%) | 15 (14.0%) | 0.1 |
HBV | 290 (88.7%) | 133 (87.5%) | 65 (95.6%) | 92 (86.0%) | |
Age(years) | 51.2 ± 9.5 | 50.7 ± 9.2 | 53.6 ± 10.4 | 50.5 ± 9.3 | 0.076 |
ALT(U/L) | 108.6 ± 371.4 | 138.1 ± 535.2 | 78.1 ± 92.2 | 86.1 ± 92.0 | 0.41 |
AST(U/L) | 80.1 ± 63.4 | 82.3 ± 63.6 | 74.2 ± 62.8 | 80.8 ± 64.0 | 0.68 |
PLT(/L) | 238.0 ± 68.9 | 241.3 ± 72.0 | 220.1 ± 59.1 | 244.6 ± 68.8 | 0.051 |
ALB(g/L) | 39.8 ± 14.3 | 38.9 ± 5.4 | 43.4 ± 29.4 | 38.9 ± 5.3 | 0.073 |
GGT(u/L) | 335.0 ± 398.9 | 358.6 ± 432.9 | 288.4 ± 280.1 | 331.2 ± 413.0 | 0.48 |
TBIL(umol/L) | 35.0 ± 51.1 | 36.4 ± 53.9 | 30.3 ± 44.1 | 36.1 ± 51.5 | 0.69 |
ALP(mmol/L) | 305.4 ± 271.7 | 306.4 ± 244.4 | 273.8 ± 261.7 | 324.2 ± 312.6 | 0.49 |
PT(s) | 12.2 ± 0.9 | 12.1 ± 0.9 | 12.2 ± 0.8 | 12.2 ± 0.9 | 0.62 |
PTA(%) | 110.9 ± 22.1 | 111.7 ± 23.3 | 107.6 ± 17.2 | 112.0 ± 22.9 | 0.38 |
INR | 1.0 ± 0.3 | 1.0 ± 0.3 | 1.0 ± 0.2 | 1.1 ± 0.4 | 0.088 |
BMI | 22.8 ± 2.8 | 23.0 ± 2.8 | 22.3 ± 2.8 | 23.0 ± 2.9 | 0.27 |
Diameter(cm) | 8.4 ± 1.5 | 8.4 ± 1.5 | 8.5 ± 1.4 | 8.2 ± 1.5 | 0.53 |
Ostime(days) | 132.3 ± 56.0 | 129.3 ± 58.7 | 133.7 ± 52.4 | 135.8 ± 54.4 | 0.63 |
